Cigna Evernorth — Non Investment Revenue decreased by 7.1% to $58.21B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 11.9%, from $52.00B to $58.21B. Over 4 years (FY 2021 to FY 2025), Evernorth — Non Investment Revenue shows an upward trend with a 16.1% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates growth in core service volume or pricing power, while a decrease may signal contract losses or reduced utilization.
This represents the total revenue generated from core pharmacy benefit management, specialty pharmacy, and medical manag...
Comparable to core service revenue metrics in other PBMs or health services organizations.
ci_segment_evernorth_health_services_non_investment_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $31.55B | $32.67B | $34.05B | $32.29B | $33.72B | $34.67B | $35.11B | $34.51B | $36.72B | $37.23B | $39.13B | $44.89B | $48.25B | $51.55B | $53.49B | $52.00B | $57.49B | $59.98B | $62.63B | $58.21B |
| QoQ Change | — | +3.5% | +4.2% | -5.2% | +4.4% | +2.8% | +1.3% | -1.7% | +6.4% | +1.4% | +5.1% | +14.7% | +7.5% | +6.8% | +3.8% | -2.8% | +10.5% | +4.3% | +4.4% | -7.1% |
| YoY Change | — | — | — | — | +6.9% | +6.1% | +3.1% | +6.9% | +8.9% | +7.4% | +11.4% | +30.1% | +31.4% | +38.5% | +36.7% | +15.9% | +19.1% | +16.4% | +17.1% | +11.9% |